
Fertifa is a London-based company that specializes in providing reproductive healthcare and wellbeing support to corporates and SMEs across the UK/IE and all of EMEA. They cater to a wide range of sectors including retail, banking, financial services, technology, and media. In the past year, Fertifa has processed over £1.5 million worth of employer-funded employee reimbursements for fertility treatments, saving patients and employers significant costs. The company has been led by renowned venture capital investor Eileen Burbidge since 2022 and recently closed a £5 million seed round.
In a challenging fundraising environment, Fertifa managed to secure funding from investors such as Notion Capital and Triple Point Ventures. This funding round reflects investors' confidence in Fertifa's traction and the significant market opportunity in reproductive, hormonal, and sexual health benefits. Fertifa is already working with companies of all sizes, from large corporates to small SMEs, in various sectors. Clients include well-known companies like lululemon, Meta, and Virgin. Fertifa has demonstrated impressive revenue growth, saving patients over £1.5 million and helping thousands of individuals navigate fertility preservation, treatment cycles, and other reproductive health journeys.
Founded in 2019 by Tony Chen and Nick Kuan, Fertifa aims to provide impartial advice and wellbeing support to individuals to make the best decisions for their unique circumstances. Eileen Burbidge, who joined as CEO in 2022, has been instrumental in expanding Fertifa's commercial footprint, partnerships, and service offering. The recent funding round will enable Fertifa to invest in its team, product, and clinical services, while also launching new services such as treatment financing. Fertifa's long-term vision is to establish itself as a trusted service provider for all personal health matters and to redefine employer-funded private pay healthcare provision in Europe.
Click here for a full list of 7,233+ startup investors in the UK